NXTS Nexentis Technologies Inc.

$NXTS Keeping an eye on this one after the AI drug-discovery update with Boltz. Low float, tiny market cap, and gaining some attention. Watching .67 for the break. If volume starts coming in, .70–.75 could be next, with .80+ possible if momentum picks up

$NXTS Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz

$NXTS Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage

$NXTS Ness Ziona, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”) recently announced that its wholly owned subsidiary, MitoCareX Bio Ltd. (“MitoCareX”), has completed an initial computational screening stage under its drug-discovery initiative with Boltz, PBC (“Boltz”), an AI research lab focused on biomolecular foundation models and drug-discovery workflows. MitoCareX believes the preliminary computational predictions generated in this stage are encouraging and warrant further computational analysis and experimental validation.

$NXTS MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis

$NXTS Nexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On Google Cloud Platform BENZINGA 6:34 AM ET 10/7/2026

$NXTS is moving on partnership following a Globe Newswire release. Nexentis subsidiary MitoCareX Bio deployed its computational drug discovery infrastructure on Google Cloud Platform to enhance capacity and data governance. RTPR pushed this release out to users at 7:32:00 AM ET

$NXTS this is a joker pump. Buyer beware. Also, this news was 2 days ago, they recirculated it again

$NXTS released that its MitoCareX Bio unit completed the first AI-driven computational screening stage with Boltz.

$NXTS according to Yahoo finance they have $6 in cash in stock I'm sorry the stock is worth $6 in cash I'm not sure what's going on here they just had a reverse split in May

$NXTS Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis

$NXTS THis has seen highest daily fall 30% and I plan to swing for some reversal by tomorrow. No reason for this to go below 1.

$NXTS stay away from this dilutive ticker. When you see a pump and dump discord you run. Don't get caught holding a bag. Will get shorted down to new lows.

$NXTS COnsistent higher low 5 min candles. Need to break above 1.2 to be strong for reversal.

$NXTS They must be diluting or big players unloading to leave the retail traders holding bags. Good luck, hope it breaks out for you all. But something seems off here

$NXTS 🔥 Boom broke through .67 and just tagged .76. Nice move off the AI/Boltz news this morning. Volume needs to keep building

$NXTS all of these shares bought yesterday and this is down. How does this make any sense

$NXTS MM stunt to reverse this from these levels after reachng almost the psyche 1 levels

$NXTS solid news 💰💸🔥🤑 Nexentis Technologies Unit MitoCareX Bio Launches Its Computational Drug Discovery Infrastructure On Google Cloud Platform

$NXTS Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud | Float: 1.1 M | IO: 4.36% | MC: 1.9 M